Hi-Tech Pharmacal nasal spray sales more than quintuple

According to New York specialty pharmaceutical company Hi-Tech Pharmacal, sales of its generic fluticasone propionate nasal spray increased 562% during the quarter ending January 31, 2011. Total sales for the product reached $17.9 million for the quarter.

The company attributes the increase to “strong unit sales at higher average prices.”

Read the company’s press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan